TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026)
TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -6.52% |
| 10 | TransMedics | 3.15 Bn | 2.67 Bn | 113.20 Mn | -21.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.85% |
| Mar 31, 2026 | 35.58% |
| Dec 31, 2025 | 113.38% |
| Sep 30, 2025 | -62.34% |
| Jun 30, 2025 | 38.77% |
| Mar 31, 2025 | -38.79% |
| Dec 31, 2024 | -176.41% |
| Sep 30, 2024 | 683,123.53% |
| Jun 30, 2024 | -5,057.48% |
| Mar 31, 2024 | 4,665.05% |
| Dec 31, 2023 | 5,391.79% |
| Sep 30, 2023 | -100.22% |
| Jun 30, 2023 | -320.62% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | -13.00% |
| Sep 30, 2022 | 11,227.54% |
| Jun 30, 2022 | 45.86% |
| Mar 31, 2022 | 13,314.29% |
| Dec 31, 2021 | 640.56% |
| Sep 30, 2021 | 428.57% |